Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity

Background: Osteoporosis is a type of systematic metabolic bone disease caused by the decrease in osteogenic activity or excessive resorption of bone with the relative enhancement of osteoclast function. As osteoporosis seriously affects the quality of patients’ life, effective drugs are needed to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Wei, Huang, YanBo, Li, HaiShang, Chen, ChiWei, Lin, YueWei, Wang, Min, Huang, HuaSheng, Liu, Teng, Qin, QiuLi, Shao, Yang, Tang, YongChao, Yuan, Kai, Ding, JinYong, Xu, LiangLiang, Li, YongXian, Zhang, ShunCong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533194/
https://www.ncbi.nlm.nih.gov/pubmed/36210855
http://dx.doi.org/10.3389/fphar.2022.1015693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533194/
https://www.ncbi.nlm.nih.gov/pubmed/36210855
http://dx.doi.org/10.3389/fphar.2022.1015693

Ejemplares similares